By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six months before and after prostate surgery improved the chances of eliminating the ...

A multimodal AI model identified a subset of men with very high-risk localized prostate cancer who derived substantial ...

Early findings show efficacy of water vapor therapy for treating intermediate-risk prostate cancer with minimal procedural ...

About six years ago, I was diagnosed with prostate cancer. I chose to have a high-intensity focused ultrasound (HIFU), which ...

For men with high-risk prostate cancer, hormone-blocking treatment significantly improves the possibility of a good outcome ...

Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver hormone therapy, according to the results of a large clinical trial led by UCL ...

Endocrine therapy is a way of treating conditions such as cancer using hormones. Also known as hormone therapy, it involves adjusting the levels of certain hormones, such as testosterone, estrogen, ...

Prostate cancer patients are set to be offered new radiation therapy expected to spare them daily treatment and spare them ...

Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, ...

June 18 (Reuters) - The U.S. health department said on Thursday it was seeking updates to labels for testosterone replacement ...

Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and death in late-stage studies. Read more at straitstimes.com. Read more at ...